EMVision Medical Devices (ASX:EMV) secures $15.3M investment from Keysight Technologies
EMVision Medical Devices secured a $15.3 million strategic investment from Keysight Technologies (NYSE:KEYS).
The investment fuels the commercialisation of EMVision’s emu device, which is set for market introduction next year.
Keysight's first-ever investment in point-of-care medical imaging reflects confidence in EMVision's technology.
The emu device integrates smoothly into acute stroke workflows.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
